Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure

We assessed the predictive factors for outcome and response in 123 patients with chronic myeloid leukemia in chronic phase treated with second-generation tyrosine kinase inhibitors (TKIs) after imatinib failure. Better event-free survival rates with second-generation TKI therapy were associated with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jabbour, Elias, Kantarjian, Hagop, O'Brien, Susan, Shan, Jenny, Garcia-Manero, Guillermo, Wierda, William, Ravandi, Farhad, Borthakur, Gautam, Rios, Mary Beth, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081281/
https://ncbi.nlm.nih.gov/pubmed/21030554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-293977
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares